Ayala Pharmaceuticals, Inc. (AYLA) Earning

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.44
Day's range
$0.57
AYLA Earnings Estimates and Actuals by Quarter-$0.5-$0.5-$0.6-$0.6-$0.7-$0.7-$0.8-$0.8Q1 2021Q1 2021Q2 2021Q2 2021Q3 2021Q3 2021Q4 2021Q4 2021Q1 2022Q1 2022Q2 2022Q2 2022Q3 2022Q3 2022Q4 2022Q4 2022
Actual EPS
Download SVG
Download PNG
Download CSV

Ayala Pharmaceuticals, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
03/31/2023 Q4 2022 N/A -$0.62 N/A N/A $105.00 K
11/03/2022 Q3 2022 -$0.49 -$0.66 -0.17 N/A $91.00 K
08/15/2022 Q2 2022 -$0.65 -$0.54 0.11 N/A $38.00 K
05/16/2022 Q1 2022 N/A -$0.66 N/A N/A $458.00 K
03/28/2022 Q4 2021 -$0.61 -$0.59 0.02 N/A $-2,360,000
11/15/2021 Q3 2021 -$0.80 -$0.68 0.12 N/A $625.00 K
08/12/2021 Q2 2021 -$0.63 -$0.75 -0.12 N/A $761.00 K
05/14/2021 Q1 2021 -$0.71 -$0.74 -0.03 N/A $974.00 K
03/24/2021 Q4 2020 N/A -$0.73 N/A N/A $1.00 M
11/16/2020 Q3 2020 -$0.55 -$0.59 -0.04 N/A $658.00 K
08/12/2020 Q2 2020 N/A -$0.74 N/A N/A $1.05 M
06/22/2020 Q1 2020 N/A -$0.54 N/A N/A $1.00 M
12/30/2019 Q4 2019 N/A -$0.45 N/A N/A $372.00 K
09/29/2019 Q3 2019 N/A -$0.59 N/A N/A $845.00 K
06/29/2019 Q2 2019 N/A -$0.44 N/A N/A $852.00 K
03/30/2019 Q1 2019 N/A -$0.41 N/A N/A $265.00 K

Ayala Pharmaceuticals, Inc. Earnings: FAQ's

Ayala Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 27th, 2023 based offlast year's report dates.

The conference call for Ayala Pharmaceuticals, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Ayala Pharmaceuticals, Inc.'s latest earnings report can be read online.

Ayala Pharmaceuticals, Inc. (:AYLA) has a recorded annual revenue of $692.00 K.

Ayala Pharmaceuticals, Inc. (:AYLA) has a recorded net income of $-38,013,000.Ayala Pharmaceuticals, Inc. has generated $-2.46 earnings per share over the last four quarters.

Ayala Pharmaceuticals, Inc. (:AYLA) has a price-to-earnings ratio of -0.22 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED